BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Gilead Reports Positive Update on Four Sofosbuvir Combo Phase IIIs in Certain HCV

  September 21, 2015

   · 

  7 min read
• Drug Development

  BerGenBio AS Release: BGB324 Enhances Immune Checkpoint Inhibitor Efficacy In Preclinical Cancer Models

  September 21, 2015

   · 

  3 min read
• Drug Development

  Ignyta Announces Entrectinib Phase I Data Presentation At The 2015 European Cancer Congress

  September 21, 2015

   · 

  4 min read
• Drug Development

  Five Prime’ Phase Ia/Ib Trial Of FPA008 And OPDIVO (Nivolumab) Featured As A Trial-In-Progress At The CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

  September 21, 2015

   · 

  5 min read
• Business

  TransBio Ltd And Dendrocyte Biotech Pty Ltd Sign Convertible License Agreement For The Development Of Antibody Drugs Targeting CD83 To Prevent Graft Versus Host Disease

  September 21, 2015

   · 

  5 min read
• Biotech Bay

  The Lies We Tell Are More Convincing When We Need To Pee, California State University, Fullerton Study

  September 21, 2015

   · 

  1 min read
• BioMidwest

  Brain-Controlled Smart Home Lets You Turn The TV On By Thinking, Gazi University Study

  September 21, 2015

   · 

  1 min read
• Genetown

  Face Analysis Can Tell What You’ll Buy After Watching Ads, Affectiva Reveals

  September 21, 2015

   · 

  1 min read
• Biotech Bay

  Why Gilead Is A Buy (Hint: It’s Not Hepatitis C)

  September 21, 2015

   · 

  1 min read
• Biotech Bay

  Why You Don’t Hate Biotech As Much As Tech -- Yet

  September 21, 2015

   · 

  1 min read